We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$441M
AUM Growth
+$91.2M
Cap. Flow
+$74.5M
Cap. Flow %
16.9%
Top 10 Hldgs %
24.04%
Holding
1,099
New
222
Increased
266
Reduced
262
Closed
55

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$15.4M
2
STLA icon
Stellantis
STLA
+$9.9M
3
ALC icon
Alcon
ALC
+$7.77M
4
AMZN icon
Amazon
AMZN
+$6.64M
5
RACE icon
Ferrari
RACE
+$5.26M

Top Sells

Rank Stock Value
1
EWT icon
iShares MSCI Taiwan ETF
EWT
+$8.02M
2
RSX
VanEck Russia ETF
RSX
+$6.88M
3
LIN icon
Linde
LIN
+$5.74M
4
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$5.13M
5
TUR icon
iShares MSCI Turkey ETF
TUR
+$4.56M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.26%
2 Technology 13.6%
3 Financials 12.86%
4 Healthcare 10.91%
5 Industrials 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLTR icon
926
Dollar Tree
DLTR
$23.1B
$588 ﹤0.01%
6
– –
APA icon
927
APA Corp
APA
$12.8B
$585 ﹤0.01%
29
– –
HAS icon
928
Hasbro
HAS
$12.6B
$585 ﹤0.01%
6
– –
EPOL icon
929
iShares MSCI Poland ETF
EPOL
$669M
$583 ﹤0.01%
27
– –
EAF icon
930
GrafTech
EAF
$194M
$566 ﹤0.01%
5
-126
-96% -$15.8K
GFL icon
931
GFL Environmental
GFL
$14.3B
$562 ﹤0.01%
18
-1,401
-99% -$45.9K
PJP icon
932
Invesco Pharmaceuticals ETF
PJP
$425M
$559 ﹤0.01%
7
– –
AAT
933
American Assets Trust
AAT
$1.49B
$554 ﹤0.01%
+15
New +$534
RACE icon
934
CALL
Ferrari
RACE
$63.3B
$539 ﹤0.01%
1
-150
-99% -$31.3K
NDAQ icon
935
Nasdaq
NDAQ
$51.5B
$537 ﹤0.01%
9
– –
FMC icon
936
FMC
FMC
$1.42B
$535 ﹤0.01%
5
– –
DBVT
937
DBV Technologies
DBVT
$807M
$529 ﹤0.01%
10
– –
DLS icon
938
WisdomTree International SmallCap Dividend Fund
DLS
$1.04B
$526 ﹤0.01%
7
-1,650
-100% -$125K
MASI
939
DELISTED
Masimo
MASI
$523 ﹤0.01%
2
– –
BR icon
940
Broadridge
BR
$17.2B
$505 ﹤0.01%
3
– –
TAK icon
941
Takeda Pharmaceutical
TAK
$55.1B
$503 ﹤0.01%
30
– –
TEVA icon
942
Teva Pharmaceuticals
TEVA
$35.9B
$501 ﹤0.01%
55
-10,979
-100% -$116K
IQV icon
943
IQVIA
IQV
$34.7B
$499 ﹤0.01%
2
– –
IOVA icon
944
Iovance Biotherapeutics
IOVA
$2.23B
$495 ﹤0.01%
20
– –
EFA icon
945
iShares MSCI EAFE ETF
EFA
$76.4B
$477 ﹤0.01%
6
– –
NNN icon
946
NNN REIT
NNN
$9.39B
$474 ﹤0.01%
10
– –
ADAP
947
DELISTED
Adaptimmune Therapeutics
ADAP
$468 ﹤0.01%
121
– –
NHI icon
948
National Health Investors
NHI
$3.9B
$467 ﹤0.01%
7
– –
BXP icon
949
Boston Properties
BXP
$11B
$465 ﹤0.01%
4
– –
TAP icon
950
Molson Coors Class B
TAP
$7.68B
$465 ﹤0.01%
9
-51
-85% -$2.85K
36 37
38
39 40

Similar funds

PC
Plaisance Capital Denver, Colorado $172M AUM 27.11% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
LPWM
Lake Point Wealth Management Rockwall, Texas $176M AUM 11.87% 1-Year Est. Return
ACM
Aquamarine Capital Management New York $170M AUM 15.49% 1-Year Est. Return
HWIS
Hancock Whitney Investment Services New Orleans, Louisiana $157M AUM
LWM
Loveless Wealth Management Billings, Montana $153M AUM 3.63% 1-Year Est. Return
EW
Emerson Wealth Bloomfield Hills, Michigan $153M AUM 16.38% 1-Year Est. Return
GDWAM
Gold Dragon Worldwide Asset Management Central, Hong Kong $151M AUM 54.24% 1-Year Est. Return

Exane Derivatives's Q2 2021 Portfolio in Review

As of Q2 2021, Exane Derivatives held 1,099 positions worth $441M, up 26% from $350M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Exane Derivatives deployed $74.5M of net new capital in Q2 2021, opening 222 new positions and adding to 266 existing holdings. Its largest new stake was Alcon: 109,041 shares worth $7.62M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MSCI Taiwan ETF, an estimated $8.02M trimmed.

  • Exane Derivatives's largest Q2 2021 buy was Alcon: 109,041 shares worth $7.62M.
  • Exane Derivatives added most to UBS Group in Q2 2021, an estimated $15.4M increase.
  • Exane Derivatives's biggest Q2 2021 reduction was iShares MSCI Taiwan ETF, cutting an estimated $8.02M.
  • Exane Derivatives fully exited Deutsche Bank in Q2 2021, selling an estimated $4.27M.
  • Exane Derivatives's ten largest holdings make up 24% of its $441M portfolio in Q2 2021.
  • Exane Derivatives opened 222 new positions and closed 55 in Q2 2021.
  • Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $441M.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.